May 01, 2014 for example, the 12 item multiple sclerosis walking scale, berg balance scale, multiple sclerosis impact scale, and visual analog scale for fatigue all received ratings of 3 or 4 for the great majority of settings and edss levels, indicating their appropriateness for tracking patient status over a longterm period or as a patient transitions. Multiple sclerosis impact scale msis29 brain oxford. Pdf italian validation of the 12item multiple sclerosis. Italian validation of the 12item multiple sclerosis. Crosscultural adaptation and validation of the 12item. Identifying an important change threshold for the multiple. Gait dysfunction is a common and relevant symptom in multiple sclerosis ms.
The most recent and best validated of these is the 12item multiple sclerosis walking scale msws12. An equation for mapping the msws 12 to the eq5d was previously developed and validated using a north american research committee on ms narcoms registry cohort. The multiple sclerosis walking scale msws12 is the predominant patientreported measure of multiple sclerosis ms elated walking ability, yet it had not been analyzed using item response theory irt, the emerging standard. Twelve item ms walking scale msws12 sailing sclerosis. Sep 23, 2015 the 12item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. Predictors were walking speed and the 12item multiple sclerosis walking scalean index of walking problems. Patients and methods patients with stable ms at 22 uk centres were randomised to oral cannabis extract. Objective multiple sclerosis ms is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. The first 12 questions of this guide are based on the 12item multiple sclerosis walking scale msws12a validated, selfreported patient questionnaire rating the effect of ms on walking.
Factors for lower walking speed in persons with multiple sclerosis. Selecting rehabilitation outcome measures for persons. Assessment of clinically meaningful improvements in self. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws 12 in the ampyra label, the lack of probased labeling claims suggests a gap in the availability of suitable pro measures for use in assessing treatment benefit in ms trials. A change will be indicated by a reduction or increase in the score over time. Validity and reliability of four clinical gait measures in. Full text mapping of multiple sclerosis walking scale msws.
Author links open overlay panel marina gonzalez del rio a miguel merchan ruiz a b. 10 an example of the baseline record form and baseline questionnaire booklet can be found at. Importance of informing patients of other important precautionary information. Ms multiple sclerosis mri magnetic resonance imaging msfc multiple sclerosis functional composite msis29 multiple sclerosis impact scale msws12 12item multiple sclerosis walking scale ncd national coverage determination nice national institute for health and care excellence nnt number needed to treat nr not reported or odds ratio. This study aimed to crossculturally adapt and validate the msws12 for the brazilian population with ms. The multiple sclerosis walking scale12 msws12 is a valid patientreported questionnaire rating walking ability in pwms.
The aim of this study is to examine the psychometric properties of the walk12g in people with multiple sclerosis ms and parkinsons disease pd. Multiple sclerosis the 12item multiple sclerosis walking scale msws 12 involves the damage to your email box. Goldman is a neurologist in charlottesville, virginia and is affiliated with one hospital. The 12item multiple sclerosis walking scale msws12 is a new, selfrated measure of walking ability. We recruited 12 consecutive patients with a known diagnosis of ms. Multiple sclerosis ms is a chronic autoimmunemediated disorder that affects approximately 1 million people in the united states. Abstract multiple sclerosis ms is a complex chronic, progressing disease that contributes to poor quality of life qol for patients and. Mapping the 12item multiple sclerosis walking scale to the. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of. The 12item multiple sclerosis walking scale msws12. Twelve item ms walking scale msws 12 graph patient progress over time twelve item ms walking scale use the graphs below to plot the percentage score from the questionnaire at each visit.
In doubleblind phase iii studies fampridine, compared with placebo, improved walking ability in adults with multiple sclerosis and walking impairment. An equation for mapping the msws12 to the eq5d was previously developed and validated using a north american research committee on ms narcoms registry cohort. Healthrelated quality of life euroqol eq5d5l and the 29item multiple sclerosis impact scale msis29 version 2. Homebased physical telerehabilitation in patients with. Mapping of multiple sclerosis walking scale msws12 to five. In the ampyra clinical trials, it was used to demonstrate the clinical meaningfulness of change in walking speed. Jun 18, 2012 in developing the patientslikeme online platform for patients with multiple sclerosis ms, we required a patientreported assessment of functional status that was easy to complete and identified disability in domains other than walking. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws 12 in the ampyra label, the lack of probased labeling claims suggests a gap in the availability of suitable pro measures for use in. Diego cadavid, neurologist in cambridge, ma us news.
This study examined the validity of the pdds based on 1 the association with expanded disability status scale. Possible secondary outcomes for the definitive trial. Walking function was assessed by the timed 25foot walk test t25fwt, the 6minute walk test 6mwt, and the 12item multiple sclerosis walking scale msws12. To map the 12item multiple sclerosis walking scale msws12 onto the euroqol 5dimension eq5d healthutility index in multiple sclerosis ms patients participating in the north american research committee on multiple sclerosis narcoms registry. Crosssectional msws 12 to eq5d cross walking analysis. Six ms outpatient clinics across italy enrolled subjects. The msws 12 is a patientrated measure of the impact of ms on walking that was developed using standard methods of test construction and validated in community and hospitalresiding samples of individuals with ms 2. The multiple sclerosis walking scale msws12 assesses the impact of ms on walking ability from the patients perspective, but in its current form, is not amenable for use in many policy decision making settings. At a glance prediction of oxygen uptake during walking in. Multiple sclerosis, outcomes, responsiveness, mobility, study design, measures of. Multiple sclerosis outcome measures taskforce apta. Self reported walking ability was measured using the multiple sclerosis walking scale 12 msws 12. Multiple sclerosis walking scale 12 version 1 msws12v1 the msws12v1 is a 12 item questionnaire that asks subjects to rate, on a 5point scale from 1not at all to 5extremely, their msrelated mobility limitations during the preceding 2 weeks.
The higher the scorepercentage, the greater the perceived impact ms is having on walking ability. Mapping the 12item multiple sclerosis walking scale to the euroqol. The msws12 is a patientrated measure of the impact of ms on walking that was developed using standard methods of test construction and validated in community and hospitalresiding samples of individuals with ms 2. Outcome measures for individuals with multiple sclerosis. Research article italian validation of the 12item multiple sclerosis. The multiple sclerosis walking scale msws12 was developed to measure the impact of multiple sclerosis on walking.
One hundred fortynine patients in the community and 53 hospital outpatients with ms completed the msws12 and other outcome measures. This study was conducted based on the recommendations published from the consensus conference on outcome measures in gait and fatigue sponsored by the consortium of multiple sclerosis centers cmsc in november. This was shown using the 12item multiple sclerosis walking scale msws12, a validated, selfreported patient questionnaire rating the effect of ms on walking. Ms multiple sclerosis msis29 multiple sclerosis impact scale msfc multiple sclerosis functional composite msws12 12item multiple sclerosis walking scale neda no evidence of disease activity nice national institute for health and care excellence pasat progression of paced auditory serial addition test. Here we report the results of the multiple sclerosis and extract of cannabis musec study that aimed to substantiate the patient based findings of previous studies. Assessing walking disability in multiple sclerosis. Multiple sclerosis outcome measures taskforce compendium of instructions for outcome measures 12. Jun 24, 2016 the multiple sclerosis walking scale msws 12 is the predominant patientreported measure of multiple sclerosis ms elated walking ability, yet it had not been analyzed using item response theory irt, the emerging standard for patientreported outcome pro validation. To map the 12 item multiple sclerosis walking scale msws 12 onto the euroqol 5dimension eq5d healthutility index in multiple sclerosis ms patients participating in the north american research committee on multiple sclerosis narcoms registry.
Walking impairment has o en been measured in clinical research and practice using the expanded disability status scale edss,thetimedfootwalktfw, theminute walk mw, and quantitative analysis gait kinematics. Pdf mapping the 12item multiple sclerosis walking scale to. This study aimed to profile gait pathology in gaitimpaired patients with ms using comprehensive 3d gait analysis and. Pdf testing patientreported outcome measurement equivalence. Walking function was assessed by the timed 25foot walk test t25fwt, the 6minute walk test 6mwt, and the 12 item multiple sclerosis walking scale msws 12. Identification and validation of clinically meaningful benchmarks in the 12item multiple sclerosis walking scale myla d goldman, melanie d ward, robert w motl, david e jones, john h pula, and diego cadavid. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of ms on the individuals walking ability. Other than for self reported ambulatory disability based on the 12 item multiple sclerosis walking scale msws12 in the ampyra label, the lack of pro based labeling claims regarding improvements in ms symptoms or functional impacts suggests a gap in that availability of suitable pro instruments for use in assessing treatment benefit in. Mos pain effects scale pes multiple sclerosis functional composite msfc multiple sclerosis quality of life54 msqol54 multiple sclerosis quality of life inventory msqli paced auditory serial addition test pasat. For the improvement of walking in adult patients with multiple sclerosis with walking disability edss expanded disability status scale 47. Hobart jc, riazi a, lamping dl, fitzpatrick r, thompson aj. Psychometric performance of a generic walking scale walk12g. Use the graphs below to plot the percentage score from the questionnaire at each visit. Guidelines and best practices for appropriate use of.
Abstract dynamometerbased measure of spasticity confirms. Jul 27, 2017 walkingmultiple sclerosis walking scale12 item msws12 version 2. Many other disabling neurological conditions affect patients ability to walk, and a generic measure of walking could provide valuable insights into patients perceptions in clinical trials and epidemiological studies as well as routine clinical practice. Mapping the 12item multiple sclerosis walking scale to the euroqol 5dimension index measure in north american multiple sclerosis patients. Crosssectional msws12 to eq5d cross walking analysis. Transcript of interview on ampyra research, ms walking. Testing patientreported outcome measurement equivalence in multinational clinical trials. Objective to map the 12item multiple sclerosis walking scale msws12 onto. Gait impairment is reported by 85% of patients with multiple sclerosis ms as main complaint. The abc discriminated between multiple fallers and nonfallers but not between men and women.
The 12item multiple sclerosis walking scale msws12 provides a patientreported outcome of the impact of ms on walking. Bi barthel index, edss expanded disability status scale, eq5d euroqol, es effect size, fams functional assessment of multiple sclerosis, ghq 12 12 item version of the general health questionnaire, msis29 multiple sclerosis impact scale, nhnn national hospital for neurology and neurosurgery, sf36 medical outcomes study 36. Preliminary psychometric evaluation data quality, scaling assumptions, acceptability, reliability, validity was undertaken in the data generated by 602 people. The patients were guided by the home telecare units. Profiling walking dysfunction in multiple sclerosis. Development, refinement, and psychometric validation using an online community. Evaluating change in mobility in people with multiple sclerosis. It consists of 12 questions concerning the limitations to walking due to ms during the past 2 weeks. To date, there is limited evidence regarding the validity of pdds scores, despite its sound conceptual development and broad inclusion in ms research. Confirming the validity and responsiveness of the multiple. A recent study confirmed the association between msws12 scores and t25fw and 6mw performance and showed the association between msws12 scores and spatial and temporal parameters of gait 8.
Most patients with multiple sclerosis ms eventually experience walking disability. The multiple sclerosis rating scale, revised msrsr. A randomized crossover trial of dalfampridine extended. Function, disability, and handicap,12 aiming to select. Sara strzok, sophie cleanthous, farrah pompilus, stefan j cano, patrick marquis, stanley cohan, myla d goldman, kiren kresareahl, jennifer petrillo and carmen castrilloviguera. Pdf mapping the 12item multiple sclerosis walking scale. Walking impairment has a major influence on the qualityoflife of people with multiple sclerosis ms. A change will be indicated by a reduction or increase. Ambulation index ai bladder control scale blcs bowel control scale bwcs disease steps ds. Multiple sclerosis outcome measures taskforce compendium of. Italian validation of the 12item multiple sclerosis walking.
The multiple sclerosis walking scale is a selfassessment scale which measures the impact of ms on walking. Gait impairment is commonly in people with multiple sclerosis ms. Selecting rehabilitation outcome measures for people with multiple. Physical therapists working with people with multiple sclerosis ms have additional. The walk12g was adapted from the 12item multiple sclerosis walking scale as. The participants completed a demographic questionnaire, including a history of falls, and. Feb 03, 2016 the 12 item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. Identification and validation of clinically meaningful.
Findings from the multinational enhance study in walking disabled participants with multiple sclerosis expanded disability status scale edss score 4. The msws12v1 was completed at screening and all scheduled and unscheduled study visits. Walking assessments had high reliability and were correlated with related measures, including the 12item multiple sclerosis walking scale msws12. Ecological validity is suggested since abc discriminated between users of assistive walking device and nonusers. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. The patient determined disease steps pdds is a promising patientreported outcome pro of disability in multiple sclerosis ms. An exemplar using the 12item multiple sclerosis walking scale. Spearman rho correlations were used to evaluate relationships between spasticity measures, measures of walking speed and endurance, and selfperceived limitations in walking.
The 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of multiple sclerosis ms on walking ability, but cannot be used in costeffectiveness or costutility analyses which require a healthutility score to calculate qualityadjusted lifeyears. The scale has not been independently validated for use in differing ms populations. Existing measures of functional status were inadequate, clinicianreported, focused on walking, and burdensome to complete. Mapping the 12item multiple sclerosis walking scale to. Sep 29, 2011 the walk12g was adapted from the 12item multiple sclerosis walking scale as a generic patientreported rating scale for walking difficulties in everyday life. Six ms outpatient clinics across italy enrolled subjects between june 20 and.
A conversation with your doctor about walking difficulty might be an important first step. May 18, 20 the 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of multiple sclerosis ms on walking ability, but cannot be used in costeffectiveness or costutility analyses which require a healthutility score to calculate qualityadjusted lifeyears. The 12item multiple sclerosis walking scale msws 12 what does this author special investigating alternative medicine but in many cases most patients to ever be truly better improving the patient has been brought on by facial movements through even with associated with multiple sclerosis before contract. The multiple sclerosis walking scale12 msws12 is a 12item selfreport.
Siponimod for the treatment of secondary progressive. Research article italian validation of the 12item multiple. Multiple sclerosis impact scale msis29 the following questions ask for your views about the impact of ms on your daytoday life during the past two weeks for each statement, please circle the one number that best describes your situation please answer all questions in the past two weeks, how much has. Validation of patient determined disease steps pdds. The original scoring provides options 15 for each item, with 1 meaning no limitation and 5 meaning extreme limitation on the gaitrelated item. The higher the scorepercentage, the greater the perceived impact ms is. The aim of this study was to crossculturally adapt and validate the msws12 for the italian population with ms. The most recent and best validated of these is the 12 item multiple sclerosis walking scale msws 12.
Original research paper development of a gait module to. The 12item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. Mapping from the multiple sclerosis walking scale msws12. As validation of scores from a measure is an ongoing and evolving process, the provision of additional evidence is warranted that confirms and extends the validity of inferences from scores on the msws 12. The 12item ms walking scale msws12 assesses patients measurement of walking quality. Importance of women informing clinicians if they are or plan to become pregnant or plan to breastfeed. Many other disabling neurological conditions affect patients ability to walk, and a generic measure of walking could provide valuable insights into patients perceptions in clinical trials and epidemiological studies as well as routine clinical. Measuring the impact of ms on walking ability neurology. Multiple sclerosis walking scale12 and oxygen cost of. This study developed an equation for predicting the energy expenditure during walking in persons with multiple sclerosis ms. Confirmation and extension of the validity of the multiple. Full text mapping of multiple sclerosis walking scale.
405 1298 740 309 1012 37 1167 522 636 504 467 1538 275 1054 889 140 198 784 1041 636 567 443 283 687 94 651 1201 249 1226 851 66 160 723 424 482 344